semaglutide skin shows potential in managing chronic condition in people with obesity Semaglutide Demonstrates Potential, Improves Outcomes

While both tirzepatide and semaglutide reduced appetite, tirzepatide's superior weight loss outcomes suggest that other mechanisms, including increased energy expenditure, also play a role

Eli Lilly reiterated to NPR that the drugs have been "available since August." "Our current manufacturing investment of over $20 billion in the past four years is the most significant in our history, and will allow us to continue increasing capacity to safely bring these medicines to people who need them," Eli Lilly spokesperson Courtney Kasinger wrote in an email

Try to aim for 7 to 9 hours of good-quality sleep each night

References American Society of Health-System Pharmacists

There is a risk of bloodborne diseases such as HIV, Hepatitis, and others